BIO-PATH HOLDINGS INC
BPTHOther · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Operating income | −$12.0M | −$15.8M | −$13.9M | −$10.4M | −$10.9M | −$8.7M |
| Net income | −$9.9M | −$16.1M | −$13.9M | −$10.4M | −$10.9M | −$8.6M |
| Total assets | $3.9M | $3.2M | $16.0M | $26.6M | $16.5M | $22.7M |
| Total liabilities | $3.7M | $2.8M | $1.8M | $1.1M | $1.4M | $1.6M |
| Equity | $154,000 | $441,000 | $14.2M | $25.5M | $15.1M | $21.1M |
| EPS (diluted) | $-4.12 | $-33.63 | $-38.12 | $-1.55 | $-2.83 | — |
| Shares out. | 678,795 | 8.0M | 7.2M | 6.9M | 3.7M | 2.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2024- Operating margin
- —
- Net margin
- —
- Return on equity
- −6424.7%
- Return on assets
- −254.8%
- Return on capital (ROCE)
- −2039.5%
- Liabilities / assets
- 96.0%
- Debt / equity
- 24.21×
- Book value / share
- $0.23
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2024- Altman Z″ (distress)
- -118.55distress
- Accruals / assets
- 17.5%high accruals
- Piotroski F-Score
- 2/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 3 warning● 0 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- High accruals — earnings-quality risk
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 15, 2026
- NT 10-Qmissed a reporting deadline ↗Nov 17, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 11, 2009
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2009
- NT 10-Qmissed a reporting deadline ↗May 15, 2008
- NT 10-Kmissed a reporting deadline ↗Sep 28, 2007
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Armistice Capital, LlcPassive (13G)May 15, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 12,824 | 1.0 | +582.1% |
| Apr 30, 2026 | 1,880 | 1.0 | -21.6% |
| Apr 15, 2026 | 2,398 | 1.0 | +24.6% |
| Mar 31, 2026 | 1,924 | 1.0 | +1.2% |
| Mar 13, 2026 | 1,902 | 1.0 | -84.3% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Regulation FD disclosure · Other material eventMay 26, 2026
- Amended charter or bylaws · Other material eventMar 20, 2026
- Change in control · Amended charter or bylaws · Regulation FD disclosure · Other material eventFeb 24, 2026
- Director / officer change · Other material eventNov 14, 2025
- Director / officer changeOct 29, 2025
- Changed auditorAug 13, 2025
- Director / officer change · Other material eventJun 24, 2025
- Other material eventMay 2, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KFORM 8-KMay 26, 2026
- 15-12GFORM 15May 22, 2026
- 10-QFORM 10-QMay 20, 2026
- NT 10-QFORM NT 10-QMay 15, 2026
- 1-KMay 1, 2026
- QUALIFApr 28, 2026
- CORRESPApr 27, 2026
- UPLOADApr 1, 2026
- 1-AMar 25, 2026
- 8-KFORM 8-KMar 20, 2026
- 1-ZFeb 25, 2026
- 8-KFORM 8-KFeb 24, 2026
- 10-QFORM 10-QJan 13, 2026
- NT 10-QEXTENSIONNov 17, 2025
- 8-KFORM 8-KNov 14, 2025
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.